Top

BY Jill Russell, Ph.D.

Researchers at The University of Texas MD Anderson Cancer Center have shown how pretreatment clonal complexity in pancreatic tumor cells leads to chemotherapy resistance, findings that could lead to better-personalized and effective combination therapies.

Tumorigenesis is an evolutionary process. “A tumor is an ecosystem composed of different cell populations, and the fittest survive,” says Alessandro Carugo, Ph.D., research scientist...

Pancreatic cancer cells

BY Jill Russell, Ph.D.

Unresectable pancreatic cancer is usually fatal because other treatments, such as radiation therapy, cannot be used. Radiation therapy causes...

BY Clayton R. Boldt, Ph.D.

Neoadjuvant therapy is treatment, such as chemotherapy or radiation, given before a patient has surgery. This approach is used in many cancer...

BY Clayton R. Boldt, Ph.D.

MD Anderson’s proteomics platform provides a valuable institutional resource, complete with state-of-the-art instruments and specialized expertise to help researchers analyze and understand thousands of cancer-related proteins. These proteins may be useful as therapeutic targets, early detection signals or biomarkers of cancer treatment response for a number of disease types, including lung, colon, breast, ovarian, pancreatic, prostate...

blood sample

BY MD Anderson staff

This is the second part of Cancer Frontline’s interview with Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology...

BY MD Anderson staff

In October 2018, the Nobel Prize in Physiology or Medicine was awarded to Jim Allison, Ph.D., chair of Immunology, for his discoveries on...

BY Katie McCallum

Pancreatic cancer is one of the most lethal types of cancer, expected to cause more than 44,000 deaths in the U.S. this year. It’s a deadly...

BY Scott Merville

Immune cells that rush to repair damage caused by inflammatory tissue are subverted to cancer-promoting allies by pancreas cells that feature...

BY Scott Merville

Deeply entrenched and mature by the time it’s found, pancreatic cancer is one of the hardest types of the disease to defeat. A Dream Team...

BY Scott Merville

Nationally, only about 9% of people diagnosed with pancreatic cancer survive five years. In most cases, the disease has spread to other organs...